MRO Enhances Executive Leadership Team with Two Healthcare Technology Veteran Hires

Matt Wildman, Chief Commercial Officer, and Moliehi Weitnauer, Chief Product Officer, join MRO to help drive growth and innovation

NORRISTOWN, Pa., Jan. 23, 2023 /PRNewswire/ — MRO, Corp. (MRO), the leading clinical data exchange platform in healthcare, announced today two key additions to the executive leadership team. Matt Wildman has joined as Chief Commercial Officer and Moliehi (Mo) Weitnauer as Chief Product Officer. MRO’s enhanced leadership team brings deep expertise in clinical data circulation and a shared passion to transform the clinical data exchange for providers, payers, and users of clinical data.

Weitnauer enjoys a robust skillset in product strategy and product management, having helped build product organizations for many leading companies. Most recently, she did so at Cotiviti, where she was senior vice president of corporate and product strategy, and FinThrive, where she led product management for the billing and denials management solutions portfolio.

“Clinical data exchange is a core challenge in the healthcare industry. MRO is at the epicenter of this industry challenge and is positioned to continue to bring unique enterprise clinical data exchange solutions to the market,” said Weitnauer. “I’m excited to join a company with deep expertise and advanced technology in clinical data exchange and I’m looking forward to driving innovation and helping shape the portfolio of solutions into the future,” she continued.

Wildman brings a wealth of experience with clinical data and technology. Prior to joining MRO, Wildman spent 20 years with Cerner Corporation in a variety of roles, including general manager of Cerner Australia, head of sales, and senior vice president of client relationships. In Wildman’s new role as chief commercial officer, he is accountable for MRO’s go-to-market strategies, market expansion, and creating deeper alignment with current and prospective clients.

“Healthcare providers are overwhelmed with requests for clinical data, a

Read the rest Read More